This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Grant L. Christian, MD; Gerald G. Krueger, MD

Arch Dermatol. 1975;111(8):997-1000.

Abstract
Eighty-three patients with moderately severe acne were entered into a doubleblind study utilizing clindamycin and placebo. Counts of comedones and pustules were made at intervals during a 13-week period. Clindamycin resulted in noticeable improvement of acne in 85% of subjects while in the placebo group improvement was present in 38%. There was also an unexplained reduction of total comedone count in the clindamycin-treated group. Severe side effects occurred in two of 44 patients receiving clindamycin (diarrhea, 1 and rash, 1); although an additional eight patients receiving clindamycin experienced mild diarrhea, discontinuation of therapy was not required. Clindamycin appears to be a valuable additional drug in the treatment of acne.

Author Affiliations
From the departments of internal medicine (Drs. Christian and Krueger) and dermatology (Dr. Krueger), University of Utah College of Medicine, Salt Lake City.

Footnotes
Accepted for publication Nov 5, 1974.

Reprint requests to 50 N Medical Dr, Salt Lake City, UT 84132 (Dr. Krueger).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Psychosomatic Dermatology: Is It Relevant?
Gupta and Voorhees
Arch Dermatol 1990;126:90-93.
ABSTRACT  

Topical Clindamycin in Acne Vulgaris: Safety and Stability
Algra et al.
Arch Dermatol 1977;113:1390-1391.
ABSTRACT  

Clindamycin for Acne
Innes
JAMA 1976;235:250-250.
ABSTRACT